Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.4 SEK | +1.38% | +2.85% | -3.83% |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Capitalization 1 | 81.85 | 534.7 | 310.1 | 1,070 | 1,236 | - | - |
Enterprise Value (EV) 1 | 81.85 | 534.7 | 310.1 | 1,029 | 1,248 | 1,381 | 1,236 |
P/E ratio | -9.69 x | - | -11.9 x | -21.8 x | -24.4 x | -25.9 x | - |
Yield | - | - | - | - | - | - | - |
Capitalization / Revenue | - | - | - | - | - | - | - |
EV / Revenue | - | - | - | - | - | - | - |
EV / EBITDA | - | -35.7 x | -11.3 x | -23.1 x | -29.3 x | -33.9 x | -33.7 x |
EV / FCF | - | - | -4.07 x | -27.9 x | -16.6 x | - | - |
FCF Yield | - | - | -24.6% | -3.59% | -6.01% | - | - |
Price to Book | - | 3.14 x | - | - | - | - | - |
Nbr of stocks (in thousands) | 40,219 | 105,262 | 137,515 | 233,775 | 280,980 | - | - |
Reference price 2 | 2.035 | 5.080 | 2.255 | 4.575 | 4.400 | 4.400 | 4.400 |
Announcement Date | 25/02/21 | 09/02/22 | 22/02/23 | 21/02/24 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales 1 | - | - | - | - | - | - | - |
EBITDA 1 | - | -14.99 | -27.51 | -44.64 | -42.65 | -40.74 | -36.7 |
EBIT 1 | - | -15.01 | -27.52 | -44.65 | -42.66 | -40.74 | -36.7 |
Operating Margin | - | - | - | - | - | - | - |
Earnings before Tax (EBT) 1 | - | -16.25 | -27.65 | -48.11 | -49.42 | -41.84 | -36.7 |
Net income 1 | -16.02 | -16.25 | -27.65 | -48.11 | -49.42 | -41.84 | -36.7 |
Net margin | - | - | - | - | - | - | - |
EPS 2 | -0.2100 | - | -0.1900 | -0.2100 | -0.1800 | -0.1700 | - |
Free Cash Flow 1 | - | - | -76.15 | -36.92 | -75 | - | - |
FCF margin | - | - | - | - | - | - | - |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - |
Announcement Date | 25/02/21 | 09/02/22 | 22/02/23 | 21/02/24 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | 11.7 | 145 | - |
Net Cash position 1 | - | - | - | 40.5 | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | -0.2754 x | -3.561 x | - |
Free Cash Flow 1 | - | - | -76.2 | -36.9 | -75 | - | - |
ROE (net income / shareholders' equity) | - | - | -14.9% | -19.8% | -46% | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - | - |
Book Value Per Share | - | 1.620 | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - |
Capex | - | - | - | - | - | - | - |
Capex / Sales | - | - | - | - | - | - | - |
Announcement Date | 25/02/21 | 09/02/22 | 22/02/23 | 21/02/24 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-3.83% | 117M | |
+18.72% | 123B | |
+14.53% | 107B | |
-2.88% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-11.83% | 16.23B | |
+1.46% | 13.43B | |
+24.22% | 11.32B |
- Stock Market
- Equities
- CRNO B Stock
- Financials Cereno Scientific AB